Performing ICH M7 risk assessment for process impurities and degradation products was targeted towards Latin America and carried out in Spanish. In this event, we explored how our software solution, Zeneth, can help you to identify potential degradation impurities in your drug development workflow. We also demonstrated how to classify potentially mutagenic impurities through our […]
Join us for our webinar, Streamlining your drug development workflow using purge calculations. This webinar was hosted in Japanese and contained pre-recorded videos with Japanese subtitles. We were delighted to have Senior Principal Scientist Andy Teasdale, presenting in this webinar. Andy is currently the chair of AstraZeneca’s Impurity advisory Board, and has developed a wealth
Streamlining your drug development workflow using purge calculations (in Japanese) Read More »
The safety, quality and clinical results of drug substances and drug products may be disrupted by the formation of nitrosamines along with other mutagenic impurities. The comprehensive development and production of innovative medicines now inevitably involves estimating impurity profiles as well as managing and monitoring them. To meet the demands of ever-increasing regulatory standards and
3rd annual genotoxic impurities summit: Nitrosamines & beyond 2023 Read More »
Nitrosamine Drug Substance-Related Impurities (NDSRIs) have become a major concern in the pharmaceutical industry due to their potential to pose serious health risks to patients. Understanding how to predict and manage the formation of NDSRIs is vital to ensure the highest quality and safety standards are met in drug development and manufacturing processes. In this
How to predict for the formation of NDSRIs Read More »
We were thrilled to be joined by a distinguished panel of experts to discuss how to establish acceptable intake (AI) limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs). NDSRIs have emerged as a significant cause for concern within the pharmaceutical industry due to their potential to pose serious health risks to patients. In order to facilitate
How to establish acceptable intake limits for NDSRIs Read More »
We attended the American College of toxicology (ACT) 2023, in Orlando Florida! ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract research organizations, academia, and consulting firms. The 44th Annual Meeting will include a wide-ranging scientific program and educational courses, with distinguished plenary speakers, the popular Poster
American College of Toxicology (ACT) Annual Meeting Read More »
We were thrilled to participate in the annual conference of the Japanese Environmental Mutagen and Genome Society (JEMS). Since its inception in 1972, the society has been dedicated to advancing fundamental research on mutagens that have substantial implications for public health. The exciting event included various symposia, poster presentations, and research presentations by experts on
52nd Annual Meeting of the Japanese Environmental Mutagen and Genome Society (JEMS) Read More »
We were delighted to co-host, ‘The Future of AI: New opportunities, data ethics and privacy’ with Transition Partners. Attendees got the latest insights on new opportunities in AI, data ethics, and data privacy. AI and data are two evolving and hot topics right now! At this roundtable event attendees had the opportunity to participate in
The Future of AI: New opportunities, data ethics and privacy Read More »
We were delighted to attend Extractables & Leachables Europe, one of the world’s leading conferences dedicated to discussing extractables and leachables. Organised by Smithers, the conference brought together E&L related governmental bodies, academia, pharmaceutical/medical device manufacturers, material suppliers and more… Lhasa Senior Global Alliances Manager, Diego Gomes attended.
Extractables & Leachables Europe Read More »
We were excited to be attend AAPS PharmSci 360, in Florida! American Association of Pharmaceutical Scientists (AAPS) is a non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. The mission of AAPS is to advance the capacity of pharmaceutical scientists to
AAPS 2023 PharmSci 360 Read More »
Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK
Tel: +44 (0)113 394 6020
© 2025 Lhasa Limited, All rights reserved | Company registration number: 01765239 |
VAT number: 396 8737 77 | Registered charity number: 290866 | Governing documents